PHKG2
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform
Also known as: PHKG2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15735
- Gene
- PHKG2
- Ensembl
- ENSG00000156873
- Chromosome
- 16
- Canonical length
- 406 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9C, also known as autosomal liver glycogenosis. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
Canonical amino-acid sequenceUniProt
406 residues, UniProt reviewed canonical sequence.
>P15735|PHKG2
1 MTLDVGPEDE LPDWAAAKEF YQKYDPKDVI GRGVSSVVRR CVHRATGHEF AVKIMEVTAE
61 RLSPEQLEEV REATRRETHI LRQVAGHPHI ITLIDSYESS SFMFLVFDLM RKGELFDYLT
121 EKVALSEKET RSIMRSLLEA VSFLHANNIV HRDLKPENIL LDDNMQIRLS DFGFSCHLEP
181 GEKLRELCGT PGYLAPEILK CSMDETHPGY GKEVDLWACG VILFTLLAGS PPFWHRRQIL
241 MLRMIMEGQY QFSSPEWDDR SSTVKDLISR LLQVDPEARL TAEQALQHPF FERCEGSQPW
301 NLTPRQRFRV AVWTVLAAGR VALSTHRVRP LTKNALLRDP YALRSVRHLI DNCAFRLYGH
361 WVKKGEQQNR AALFQHRPPG PFPIMGPEEE GDSAAITEDE AVLVLGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PHKG2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 124 nTPM
Expression across tissuesHPA
Tissue
- testis: 124 nTPM
- bone marrow: 28 nTPM
- cerebral cortex: 19 nTPM
- liver: 18 nTPM
- choroid plexus: 18 nTPM
- parathyroid gland: 18 nTPM
Single-cell type
- late spermatids: 2,900 nCPM
- late primary spermatocytes: 479 nCPM
- early spermatids: 362 nCPM
- syncytiotrophoblasts: 104 nCPM
- early primary spermatocytes: 60 nCPM
- extravillous trophoblasts: 53 nCPM
Immune cell
- eosinophil: 115 nTPM
- NK-cell: 64 nTPM
- intermediate monocyte: 57 nTPM
- classical monocyte: 56 nTPM
- myeloid DC: 52 nTPM
- total PBMC: 49 nTPM
Brain region
- hippocampal formation: 25 nTPM
- pons: 25 nTPM
- medulla oblongata: 22 nTPM
- thalamus: 22 nTPM
- basal ganglia: 22 nTPM
- midbrain: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PHKG2.
Disease | AllUniProt
Conditions PHKG2 is implicated in, by any mechanism.
- Glycogen storage disease 9C (GSD9C) MIM:613027
Disease | GeneticClinVar
54 pathogenic / likely-pathogenic of 441 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Glycogen storage disease IXc
- Glycogen phosphorylase kinase deficiency
- Inborn genetic diseases
- Glycogen storage disease type IXc
- PHKG2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.66
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- generation of precursor metabolites and energy
- glycogen catabolic process
- glycogen metabolic process
- positive regulation of glycogen catabolic process
- protein phosphorylation
- signal transduction
Molecular functions
- ATP binding
- calmodulin binding
- enzyme binding
- phosphorylase kinase activity
- protein serine/threonine kinase activity
- tau-protein kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PHKG2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PHKG2 as an antibody target. Whether an autoantibody or antibody against PHKG2 could matter depends on whether native PHKG2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PHKG2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PHKG2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...